Published in Inflammation on August 01, 2016
Defining a link with asthma in mice congenitally deficient in eosinophils. Science (2004) 5.20
An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol (2007) 2.46
The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J Clin Invest (2006) 1.93
Importance of cytokines in murine allergic airway disease and human asthma. J Immunol (2010) 1.86
Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. Am J Respir Crit Care Med (1999) 1.62
Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res (2001) 1.57
Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J Allergy Clin Immunol (2001) 1.32
Treatment of allergic asthma: modulation of Th2 cells and their responses. Respir Res (2011) 1.31
The neutrophil-activating protein of Helicobacter pylori down-modulates Th2 inflammation in ovalbumin-induced allergic asthma. Cell Microbiol (2008) 1.25
Th17-mediated inflammation in asthma. Curr Opin Immunol (2013) 1.23
Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma. J Immunol (2000) 1.13
Risk factors for asthma: is prevention possible? Lancet (2015) 1.13
The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent. FEMS Immunol Med Microbiol (2007) 1.13
Asthma: pathogenesis and novel drugs for treatment. BMJ (2014) 1.12
Targeting the interleukin pathway in the treatment of asthma. Lancet (2015) 1.09
Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma. Chin Med J (Engl) (2011) 1.04
Emerging roles of T helper subsets in the pathogenesis of asthma. Immunol Invest (2010) 1.03
Targeting interleukin-4 in asthma: lost in translation? Am J Respir Cell Mol Biol (2012) 0.99
A new era of targeting the ancient gatekeepers of the immune system: toll-like agonists in the treatment of allergic rhinitis and asthma. Int Arch Allergy Immunol (2014) 0.97
Helicobacter pylori, asthma and allergy. FEMS Immunol Med Microbiol (2009) 0.97
Th2 cells as targets for therapeutic intervention in allergic bronchial asthma. Expert Rev Mol Diagn (2009) 0.93
The role of regulatory T cells in respiratory infections and allergy and asthma. Curr Allergy Asthma Rep (2010) 0.90
Biologic targeted therapy in allergic asthma. Ann Allergy Asthma Immunol (2014) 0.90
Helicobacter pylori neutrophil-activating protein: from molecular pathogenesis to clinical applications. World J Gastroenterol (2014) 0.88
Th2 cytokine antagonists: potential treatments for severe asthma. Expert Opin Investig Drugs (2012) 0.86
Interleukin-17 cytokine signalling in patients with asthma. Eur Respir J (2014) 0.86
FOXP3(+)Treg/Th17 cell imbalance in lung tissues of mice with asthma. Int J Clin Exp Med (2015) 0.84
Relation between inflammation and symptoms in asthma. Allergy (2009) 0.82
Helicobacter pylori neutrophil-activating protein: a potential Treg modulator suppressing allergic asthma? Front Microbiol (2015) 0.79
Helicobacter pylori-derived neutrophil-activating protein increases the lifespan of monocytes and neutrophils. Cell Microbiol (2010) 0.78
A promising approach for asthma treatment by multiwayly modulating toll-like receptors. Eur Rev Med Pharmacol Sci (2012) 0.77
Astragalin Attenuates Allergic Inflammation in a Murine Asthma Model. Inflammation (2015) 0.76